IVF and retinoblastoma revisited

Testing of retinoblastoma tumors provides no proof for epigenetic hypermethylation of the RB1 promoter in retinoblastoma tumors of children conceived by IVF or ICSI.

0
0
Upvote 0 Comment

Authors

Charlotte J. Dommering, M.D., Annemarie H. van der Hout, Ph.D., Hanne Meijers-Heijboer, M.D., Ph.D., Tamara Marees, Ph.D., Annette C. Moll, M.D., Ph.D.

Volume 97, Issue 1 , Pages 79-81

Abstract

Objective:

To evaluate the suggested association between IVF, retinoblastoma, and tumor methylation characteristics.

Design:

Laboratory analysis.

Setting:

National Retinoblastoma Center in the Netherlands.

Patient(s):

Retinoblastoma tumors from seven children conceived by IVF or intracytoplasmic sperm injection (ICSI).

Intervention(s) and Main Outcome Measure(s):

DNA from frozen retinoblastoma tumors was tested for mutations in the RB1 gene and for methylation status of the RB1 promoter.

Result(s):

For all tumors two causative RB1 mutations were found. None of the tumors showed hypermethylation of the RB1 promoter.

Conclusion(s):

Examination of retinoblastoma tumors of seven children conceived by IVF or ICSI did not show hypermethylation of the RB1 promoter. This demonstrates that an association between IVF or ICSI and retinoblastoma through this epigenetic mechanism is unlikely.

Read the full text at: http://www.fertstert.org/article/S0015-0282(11)02720-8/fulltext

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.